And the 10k may not be the panacea we expect. As I
Post# of 36537
(Total Views: 283)
Posted On: 10/21/2019 4:56:59 PM
And the 10k may not be the panacea we expect. As I understand it, a number of GNBT initiatives are not really in a mass production phase. Some appear to be in holding mode, awaiting needed financing. So I’ll take every positive from the filing but I’m anticipating more circumstance than pomp. Just the old “under-expect is better insurance than over-anticipate” theory at work.
(1)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼